In response

Advances in Anatomic Pathology

Volumn 15, Issue 3, 2008, Pages 179-180

  Mangray, Shamlal ^a   DeLellis, Ronald A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HRPT2 PROTEIN; PARAFIBROMIN;

CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; GENE MUTATION; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PARATHYROID CARCINOMA; PRIORITY JOURNAL; STAINING;

EID: 42549114736     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181709f83     Document Type: Letter

References (3)

1. Cetani F, Ambrogini E, Viacava P, et al. Should parafibromin staining replace HRPT2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol. 2007;156:547-554.
2. Gill AJ, Clarkson A, Gimm O, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinoma and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol. 2006;30:1140-1149.
3. Mangray S, Kurek KC, Sabo E, et al. Immunohistochemical expression of parafibromin is of limited value in distinguishing parathyroid carcinoma from adenoma. Abstract accepted for presentation at the United States and Canadian Academy of Pathology Annual Meeting, Denver, CO, March 1-7, 2008.